Matrix Lung, a pioneering European Health Data Warehouse dedicated to clinical research in thoracic oncology.

The Groupe Français de Pneumo-Cancérologie (GFPC), in partnership with Heva and Euris Health Cloud, announces « Matrix Lung », a pioneering Health Data Warehouse (HDW) for thoracic oncology. Authorized by the CNIL in 2023, this Data Warehouse offers alternatives to randomized trials, facilitates research and guarantees secure data management. Matrix Lung is now open to innovative research projects, marking a crucial step forward in the landscape of medical research in thoracic oncology.

Faced with the limitations of randomized trials, in particular the difficulty of gathering sufficient numbers of patients, Matrix Lung opens the way to alternative trials designed to minimize patient exposure to ineffective treatments, but also to include rare patients, develop prevention plans and participate in research in this domain.

Health Data Warehouses, such as Matrix Lung, are based on a legal, organizational and technical framework developed by Euris Health Cloud® and validated by the French Data Protection Authority (CNIL). This framework protects patients, while enabling their health data to be valorized and exploited, thus opening the door to the use of artificial intelligence. This advance is a crucial step in the evolution of clinical research in thoracic oncology, enabling the discovery of new therapeutic solutions, more frequent and rapid experimentation, and marking the beginning of a promising era in the fight against lung disease.

As a trusted third party and certified healthcare data host, Euris Health Cloud provides a sovereign, secure architecture that complies with the Data Warehouse standards of the authoroty. The Euris Health Cloud® Data Warehouse platform is a turnkey, agile and cost-effective industrial solution. Using this solution enables the GFPC and Heva to concentrate fully on analyzing the data collected, thus accelerating advances in clinical research. Going beyond a simple Data Warehouse, Matrix Lung aims to become a reference environment for multicenter studies with a European and international vocation.

By opening up its Data Warehouse and its Data to external research projects, Matrix Lung wishes to encourage international collaborations to strengthen research in the field of thoracic cancers. Matrix Lung represents a new chapter in clinical research, proposing alternatives, exploring new approaches through Health Data Warehouses, and fostering global collaboration to improve understanding and treatment of lung pathologies.